LNWTC
CRL icon

Laird Norton Wetherby Trust Company’s Charles River Laboratories CRL Stock Holding History

Laird Norton Wetherby Trust Company’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$700K Buy
3,088
+285
+10% +$50.8K 0.01% 619
2026
Q1 		$484K Sell
2,803
-37
-1% -$6.86K 0.01% 701
2025
Q4 		$567K Buy
+2,840
New +$515K 0.01% 676

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Laird Norton Wetherby Trust Company's CRL Position: Q2 2026 in Review

Laird Norton Wetherby Trust Company increased its Charles River Laboratories (CRL) stake by 10% in Q2 2026, buying an estimated $50.8K and bringing the position to 3,088 shares worth $700K. The position accounts for 0.01% of the portfolio, ranked #619.

Laird Norton Wetherby Trust Company first reported a position in CRL in Q4 2025 and has held it in 3 quarters since. 565 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Laird Norton Wetherby Trust Company held 3,088 shares of Charles River Laboratories worth $700K as of Q2 2026.
  • Laird Norton Wetherby Trust Company bought 285 Charles River Laboratories shares in Q2 2026, an estimated $50.8K.
  • Charles River Laboratories made up 0.01% of Laird Norton Wetherby Trust Company's portfolio in Q2 2026, its #619 holding.
  • Laird Norton Wetherby Trust Company first reported a position in Charles River Laboratories in Q4 2025 and has held it in 3 quarters since.
  • 565 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Laird Norton Wetherby Trust Company's 13F filing for Q2 2026, filed 14 Aug 2026.